Disparities in the Utilization of Radiation Therapy for Prostate Cancer in the United States: A Comprehensive Review

Gardner, Ulysses; McClelland, Shearwood; Deville, Curtiland

doi:10.1016/j.adro.2022.100943

Cited by 14 publications

(12 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Black, Hispanic, and Asian men were also less likely to receive proton therapy or stereotactic body RT. 8 Minorityserving hospitals were less likely to offer definitive treatments for prostate cancer, Medicaid patients were less likely to receive definitive treatments, and rural residents were less likely to receive RT, all compared with their nonminoritized counterparts. 8 In a similar vein, Black women are 40% more likely to die from breast cancer compared with White women, and death rates of stomach cancer and multiple myeloma are more than twofold higher for Black patients than for White patients.…”

Section: The Current State Of Cancer Health Disparities In the United...mentioning

confidence: 95%

Perspectives on Disparities and Equity in Cancer Outcomes: A Call to Action

Odunsi¹

2023

Academic Medicine

View full text Add to dashboard Cite

Despite remarkable progress in cancer prevention, treatment, and survivorship in the United States over the past 3 decades, there remain considerable disparities in cancer incidence and mortality among various groups based on race, ethnicity, and other social determinants of health. For most cancer types, African Americans have the highest mortality rate and lowest survival rate of any racial and ethnic group. Here the author highlights some of the factors responsible for cancer health disparities and proposes that cancer health equity is a fundamental human right. These factors include inadequate health insurance coverage, medical mistrust, lack of diversity in the workforce, and social and economic exclusion. Recognizing that health disparities do not exist in isolation but are part of a complex set of problems associated with education, housing, employment, health insurance, and community structures, the author contends that the challenge cannot be solved by public health measures alone but would require a multifaced and coordinated approach involving several sectors of the economy-business, schools, financial institutions, agriculture, and urban planning. Several immediate and

show abstract

Section: The Current State Of Cancer Health Disparities In the United...mentioning

confidence: 95%

Perspectives on Disparities and Equity in Cancer Outcomes: A Call to Action

Odunsi¹

2023

Academic Medicine

View full text Add to dashboard Cite

show abstract

“…radiation; Medicaid patients were less likely to receive definitive treatments; rural residents were less likely to receive radiation; and patients at hospitals serving minority individuals were less likely to undergo definitive treatments for prostate cancer. 12…”

Section: Practical Applicationsmentioning

confidence: 99%

Health Disparities in Prostate Cancer and Approaches to Advance Equitable Care

Washington

Goldstein

Moore

et al. 2022

American Society of Clinical Oncology Educational Book

Self Cite

View full text Add to dashboard Cite

The American Cancer Society estimates approximately 268,490 new cases of prostate cancer and approximately 34,500 deaths caused by prostate cancer in the United States for 2022. Globally, a total of 1,414,259 new cases of prostate cancer and 375,304 related deaths were reported in 2020. Well-documented health disparities and inequities exist along the continuum of care for prostate cancer management—from screening to diagnostic and staging work-up, surveillance, and treatment—ultimately impacting clinical outcomes. This session-based article discusses innovative patient-centered approaches to advance equitable prostate cancer care. It begins with a review of domestic health disparities in diagnostic imaging and radiotherapy for prostate cancer, and it summarizes barriers and solutions to achieving health equity, such as equity metrics and practice quality improvement projects. Next, a global perspective is provided that describes approaches to address financial and geographic barriers to prostate cancer care, including specific examples of strategies that emphasize the use of the cheapest method of care delivery while maintaining outcomes for drug delivery and radiotherapy.

show abstract

“…Although there may have been some improvements in delivery of surgery and radiotherapy in recent years, lack of trained staff and facilities remains a major barrier to optimize the treatment of patients with GUm. Very limited access to anticancer drugs has been highlighted in a recent survey (22,46,47).…”

Section: Resources In Lmicmentioning

confidence: 99%

Access of new systemic therapies for Genito-urinary cancers in low-middle income countries

Herchenhorn¹,

Freire²

2022

Front. Urol.

View full text Add to dashboard Cite

The availability of new systemic therapies associated with better outcomes and survival for GU tumors is a major obstacle for most LMIC. Strategies to improve access are necessary and depend not only on drug availability, but from public health care system organization, discussion and priorities as well as strategies to decrease cost by rational treatment decision and individualize use of systemic therapies in limited resource countries. Efforts should be implemented to provide more real-world data coming from LMIC and studies focusing in strategies to decrease drug costs are urgently needed.

show abstract

Disparities in the Utilization of Radiation Therapy for Prostate Cancer in the United States: A Comprehensive Review

Cited by 14 publications

References 38 publications

Perspectives on Disparities and Equity in Cancer Outcomes: A Call to Action

Perspectives on Disparities and Equity in Cancer Outcomes: A Call to Action

Health Disparities in Prostate Cancer and Approaches to Advance Equitable Care

Access of new systemic therapies for Genito-urinary cancers in low-middle income countries

Contact Info

Product

Resources

About